Sylwer fod y cymhwysiad hwn dan ddatblygiad. Os ydych chi'n gweld unrhyw gamgymeriadau neu os nad yw rhywbeth yn gweithio, cysylltwch â ni yn evidence.service@wales.nhs.uk.

Incentives for smoking cessation

Notley C et al (2019)

Cochrane Database of Systematic Reviews - 10.1002/14651858.CD004307.pub6.

Mapiau Tystiolaeth

  • Lleoliadau Gofal: Lleoliad gofal iechyd
  • Lleoliadau Gofal: Lleoliad cymunedol
  • Lleoliadau Gofal: Lleoliad gweithle
  • Grwpiau Poblogaeth: Oedolion
  • Grwpiau Poblogaeth: Chyflyrau iechyd sy'n bodoli eisoes
  • Grwpiau Poblogaeth: Beichiogrwydd / ôl-esgor
  • Grwpiau Poblogaeth: Hanes blaenorol o gamddefnyddio sylweddau
  • Ymyriadau: Therapïau seicogymdeithasol eraill
  • Canlyniad: Rhoi'r gorau i ysmygu

Math o Dystiolaeth

Adolygiad Systematig

Nodau

Mae'r awduron yn datgan:

"To determine the long-term effect of incentives and contingency management programmes for smoking cessation."

Canfyddiadau

Mae'r awduron yn datgan:

"Thirty-three mixed-population studies met our inclusion criteria, covering more than 21,600 participants; 16 of these are new to this version of the review. Studies were set in varying locations, including community settings, clinics or health centres, workplaces, and outpatient drug clinics. Incentives offered included cash payments or vouchers for goods and groceries, offered directly or collected and redeemable online. The pooled RR for quitting with incentives at longest follow-up (six months or more) compared with controls was 1.49 (95% CI 1.28 to 1.73; 31 RCTs, adjusted N = 20,097; I2 = 33%). Results were not sensitive to the exclusion of six studies where an incentive for cessation was offered at long-term follow up (result excluding those studies: RR 1.40, 95% CI 1.16 to 1.69; 25 RCTs; adjusted N = 17,058; I2 = 36%), suggesting the impact of incentives continues for at least some time after incentives cease.

Although not always clearly reported, the total financial amount of incentives varied considerably between trials, from zero (self-deposits), to a range of between USD 45 and USD 1185. There was no clear direction of effect between trials offering low or high total value of incentives, nor those encouraging redeemable self-deposits.

We included 10 studies of 2571 pregnant women. We judged two studies to be at low risk of bias, one at high risk of bias, and seven at unclear risk. When pooled, the nine trials with usable data (eight conducted in the USA and one in the UK), delivered an RR at longest follow-up (up to 24 weeks post-partum) of 2.38 (95% CI 1.54 to 3.69; N = 2273; I2 = 41%), in favour of incentives."

 

Casgliadau

Mae'r awduron yn datgan:

"Overall there is high-certainty evidence that incentives improve smoking cessation rates at long-term follow-up in mixed population studies. The effectiveness of incentives appears to be sustained even when the last follow-up occurs after the withdrawal of incentives.There is also moderate-certainty evidence, limited by some concerns about risks of bias, that incentive schemes conducted among pregnant smokers improve smoking cessation rates, both at the end of pregnancy and post-partum. Current and future research might explore more precisely differences between trials offering low or high cash incentives and self-incentives (deposits), within a variety of smoking populations."